COMMUNIQUÉS West-GlobeNewswire

Burcon Announces Fiscal 2018 Results and Reviews Operations
18/06/2018
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX:BU), a leader in natural product extraction, purification and isolation technologies, reported results for the year [...]
CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social
18/06/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 18 juin 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
CROSSJECT : Descriptif du programme de rachat d'actions 2018-2019
18/06/2018
Communiqué de Presse Descriptif du programme de rachat d'actions 2018-2019 Dijon, le 18 juin 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un [...]
Sanofi: Disclosure of trading in own shares
18/06/2018
Attachment Disclosure of trading in own shares.pdf
Sanofi : Déclaration des transactions sur actions propres
18/06/2018
Pièce jointe Déclaration des transactions sur actions propres.pdf
Ossur Hf : Transactions in relation to share buyback program
18/06/2018
Announcement no. 40/2018 Reykjavik, 18 June 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
TG Therapeutics, Inc. Announces Updated Results from the Ongoing Phase 2 Study of Ublituximab in Patients with Multiple Sclerosis at the 4th Congress of the European Academy of Neurology
18/06/2018
NEW YORK, June 18, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced updated results from the Phase 2 multicenter trial of ublituximab (TG-1101), the Company’s novel glycoengineered anti-CD20 [...]
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018
18/06/2018
GENFIT: OUTCOME OF THE ORDINARY AND EXTRAORDINARY SHAREHOLDERS' MEETING OF JUNE 15, 2018 Lille (France), Cambridge (Massachusetts, United States), June 18, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a [...]
GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 15 JUIN 2018
18/06/2018
GENFIT : RESULTATS DE L'ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 15 JUIN 2018 Lille (France), Cambridge (Massachusetts, Etats-Unis), le 18 juin 2018 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société [...]
IllumiCare integrates with Epic at multiple customers
18/06/2018
BIRMINGHAM, Ala., June 18, 2018 (GLOBE NEWSWIRE) -- IllumiCare, a pioneer in point-of-care healthcare information technology, announces today integrations with multiple health systems using the Epic electronic medical [...]
Dyadic International Improves Monoclonal Antibody (mAb) Productivity Utilizing C1 Gene Expression Platform to Manufacture Biologics
18/06/2018
Results Highlighted in BioProcess International and the Global Bioprocessing and Bioanalytics Congress 2018 JUPITER, Fla., June 18, 2018 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global [...]
PotNetwork Holdings, Inc. to File SEC Form 10 to Become Fully Reporting Company
18/06/2018
Company Prepares to Meet Uplisting Requirements to Achieve OTCQB Designation FT LAUDERDALE, Fla., June 18, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holdings, Inc. (OTC Pink:POTN) announced today that its [...]
OrthoPediatrics Corp. Announces First RESPONSE Spine Surgery Performed in Japan
18/06/2018
WARSAW, Ind., June 18, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the first [...]
Oncobiologics Announces Randy Thurman as Executive Chairman of the Board of Directors and Lawrence A. Kenyon as Interim CEO
18/06/2018
CRANBURY, N.J., June 18, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that Pankaj Mohan, Ph.D., its Chairman and Chief Executive Officer (CEO), has stepped down as CEO and Chairman of the [...]
Cannabix Technologies Provides Technology Update on Marijuana Breathalyzer Development
18/06/2018
The Cannabix Marijuana Breathalyzer is being developed to give law enforcement and employers a tool to enforce public safety VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE [...]
Maple Leaf Announced Closing of First Tranche of Non-Brokered Private Placement
18/06/2018
CALGARY, Alberta, June 18, 2018 (GLOBE NEWSWIRE) -- Maple Leaf Green World Inc. (“ Maple Leaf ” or the “ Company ”) (NEO:MGW) (OTCQB:MGWFF) is pleased to announce that it has closed the first tranche of its previously [...]
International Endeavors Corp. Now Offers Customer Financing for Lease/Purchase of Off Grid Grow Lab
18/06/2018
TEMECULA, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corp (OTC:IDVV) is pleased to announce that for customers who qualify, financing is now available for the purchase or [...]
Pascal Biosciences Receives DEA Schedule I License for Cannabinoid Development and Renews UBC Collaboration
18/06/2018
VANCOUVER, British Columbia, June 18, 2018 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX-V:PAS) ( Pascal ), is pleased to announce significant progress in its cannabinoid based research and development program with [...]
Albireo Appoints Jason G. Duncan as General Counsel and Secretary
18/06/2018
BOSTON, June 18, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the appointment of Jason G. [...]

Pages